Vivat V - Search Results

1

Purification of the human RARgamma ligand-binding domain and crystallization of its complex with all-trans retinoic acid.

Rochel N, Renaud JP, Ruff M, Vivat V, Granger F, Bonnier D, Lerouge T, Chambon P, Gronemeyer H, Moras D. Rochel N, et al. Among authors: vivat v. Biochem Biophys Res Commun. 1997 Jan 13;230(2):293-6. doi: 10.1006/bbrc.1996.5787. Biochem Biophys Res Commun. 1997. PMID: 9016769

2

Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D. Renaud JP, et al. Among authors: vivat v. Nature. 1995 Dec 14;378(6558):681-9. doi: 10.1038/378681a0. Nature. 1995. PMID: 7501014

3

A canonical structure for the ligand-binding domain of nuclear receptors.

Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, Gronemeyer H. Wurtz JM, et al. Among authors: vivat v. Nat Struct Biol. 1996 Jan;3(1):87-94. doi: 10.1038/nsb0196-87. Nat Struct Biol. 1996. PMID: 8548460

4

Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains.

Bourguet W, Vivat V, Wurtz JM, Chambon P, Gronemeyer H, Moras D. Bourguet W, et al. Among authors: vivat v. Mol Cell. 2000 Feb;5(2):289-98. doi: 10.1016/s1097-2765(00)80424-4. Mol Cell. 2000. PMID: 10882070 Free article.

5

Ligand-dependent interaction of nuclear receptors with potential transcriptional intermediary factors (mediators).

Le Douarin B, vom Baur E, Zechel C, Heery D, Heine M, Vivat V, Gronemeyer H, Losson R, Chambon P. Le Douarin B, et al. Among authors: vivat v. Philos Trans R Soc Lond B Biol Sci. 1996 Apr 29;351(1339):569-78. doi: 10.1098/rstb.1996.0056. Philos Trans R Soc Lond B Biol Sci. 1996. PMID: 8735280 Review.

6

Sequences in the ligand-binding domains of the human androgen and progesterone receptors which determine their distinct ligand identities.

Vivat V, Gofflo D, Garcia T, Wurtz JM, Bourguet W, Philibert D, Gronemeyer H. Vivat V, et al. J Mol Endocrinol. 1997 Apr;18(2):147-60. doi: 10.1677/jme.0.0180147. J Mol Endocrinol. 1997. PMID: 9134501

7

A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.

Vivat V, Zechel C, Wurtz JM, Bourguet W, Kagechika H, Umemiya H, Shudo K, Moras D, Gronemeyer H, Chambon P. Vivat V, et al. EMBO J. 1997 Sep 15;16(18):5697-709. doi: 10.1093/emboj/16.18.5697. EMBO J. 1997. PMID: 9312028 Free PMC article.

8

Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.

Géhin M, Vivat V, Wurtz JM, Losson R, Chambon P, Moras D, Gronemeyer H. Géhin M, et al. Among authors: vivat v. Chem Biol. 1999 Aug;6(8):519-29. doi: 10.1016/S1074-5521(99)80084-2. Chem Biol. 1999. PMID: 10421757

9

A canonical structure for the ligand-binding domain of nuclear receptors.

Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, Gronemeyer H. Wurtz JM, et al. Among authors: vivat v. Nat Struct Biol. 1996 Feb;3(2):206. doi: 10.1038/nsb0296-206. Nat Struct Biol. 1996. PMID: 8564548 No abstract available.

10

Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1.

vom Baur E, Zechel C, Heery D, Heine MJ, Garnier JM, Vivat V, Le Douarin B, Gronemeyer H, Chambon P, Losson R. vom Baur E, et al. Among authors: vivat v. EMBO J. 1996 Jan 2;15(1):110-24. EMBO J. 1996. PMID: 8598193 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters